Matching slides 303,780
Current window 221,641-221,670
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

221,641-221,670 of 303,780

filter-aware
13
The slide displays historical performance of capital ratios from Q2 2019 to Q2 2023.Old Second Bancorp | Investor Conference Presentation Deck | 21 slides · Old Second Bancorp
Conference presentation Investor relations Beat · What Could Be1 hit
14
Old Second Bancorp | Investor Conference Presentation Deck | 21 slidesOld Second Bancorp | Investor Conference Presentation Deck | 21 slides · Old Second Bancorp
Conference presentation Investor relations Beat · New Bliss1 hit
15
Includes footnotes regarding CECL adoption, subordinated debentures, and non-GAAP reconciliation.Old Second Bancorp | Investor Conference Presentation Deck | 21 slides · Old Second Bancorp
Conference presentation Investor relations Beat · New Bliss1 hit
16
Includes a footnote regarding CECL transitional adjustment.Old Second Bancorp | Investor Conference Presentation Deck | 21 slides · Old Second Bancorp
Conference presentation Investor relations Beat · New Bliss1 hit
18
Old Second Bancorp | Investor Conference Presentation Deck | 21 slidesOld Second Bancorp | Investor Conference Presentation Deck | 21 slides · Old Second Bancorp
Conference presentation Investor relations Beat · New Bliss1 hit
19
The table reconciles GAAP interest income and net interest income to taxable-equivalent (TE) figures.Old Second Bancorp | Investor Conference Presentation Deck | 21 slides · Old Second Bancorp
Conference presentation Investor relations Beat · New Bliss1 hit
21
The slide provides a detailed breakdown of adjustments made to GAAP figures to arrive at non-GAAP metrics.Old Second Bancorp | Investor Conference Presentation Deck | 21 slides · Old Second Bancorp
Conference presentation Investor relations Beat · New Bliss1 hit
01
Slide 1
Includes company name, ticker symbol, and date.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations 1 hit
02
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations 1 hit
04
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations 1 hit
09
The chart shows a steady increase in clinical programs from 2016 to mid-2023.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a process-oriented header (Create, Screen, Deliver) and lists specific proprietary technologies (OmniRat, OmniMouse, etc.) alongside value propositions.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide illustrates the genetic mechanism of the platform, showing how human V, D, and J genes are combined with rat constant regions to facilitate robust immune responses, followed by conversion to fully human antibodies.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Uses a phylogenetic-style timeline to show the split between avian and mammalian lineages.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
Includes a scientific citation (Stanfield et al. Sci Adv 2020) and mentions 'Picobodies' as a specific product/format.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide uses a hybrid layout combining a gallery of antibody structural diagrams with a pie chart representing market/clinical distribution.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a process diagram to contrast two distinct R&D workflows.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
The slide highlights the third stage of a three-part process (Create, Screen, Deliver).OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
23
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
The slide uses a stacked bar/area hybrid chart to visualize deal economics over time, including upfront fees, milestones, and royalties.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
The table displays revenue, operating expenses, and net loss figures in millions, along with per-share data.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
29
The slide includes a summary of financial health and cash runway expectations.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
30
The table displays financial performance in millions of dollars, highlighting a mix of revenue streams and operating costs.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
31
The table provides a year-over-year variance analysis for key financial line items.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
32
The slide provides a quantitative summary of the capital structure as of June 30, 2023.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
35
The slide uses a Gantt-style visualization to show the progress of drug candidates through clinical phases.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
02
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Attention1 hit
03
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Attention1 hit
05
OmniAb | Results Presentation Deck | 20 slidesOmniAb | Results Presentation Deck | 20 slides · OmniAb
Conference presentation Investor relations Beat · Need1 hit